Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Endometrial Neoplasms × LHRH, lysine(6)-doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1

Interventions

pembrolizumab 14 Paclitaxel 14 Carboplatin 10 Bevacizumab 6 rucaparib 5 lenvatinib 5 Megestrol Acetate 5 Radiation 4 Nivolumab 4 Indocyanine Green 4 tisotumab vedotin 3 temsirolimus 3 Sirolimus 3 Sentinel Lymph Node Biopsy 3 Doxorubicin 3 olaparib 2 ixabepilone 2 iso-sulfan blue 2 irosustat 2 epacadostat 2 durvalumab 2 copanlisib 2 Taxes 2 Metformin 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Ipilimumab 2 Gemcitabine 2 Fulvestrant 2 Cisplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01767155 2018-07-31

ZoptEC

AEterna Zentaris

Phase 3 Completed

511 enrolled 16 charts

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡